Research Triangle Park, N.C., San Diego, Tarrytown, N.Y., February 7, 2012 – Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen — marking a major step for Siemens into this important and fast-growing segment of the in vitro diagnostics (IVD) market. Both partnerships intend to leverage the clinical trial and commercialization options within Siemens’ CLIA laboratory, as well as Siemens’ established IVD clinical and regulatory expertise. More

Tarrytown, NY., February 3, 2012 – The Siemens Healthcare Diagnostics Mycophenolic Acid assay (MPAT) is now available for use on the company’s portfolio of Dimension® Integrated Chemistry Systems in the U.S. With this addition, the company becomes the first laboratory diagnostics solutions provider in the nation to offer the consolidation of four fully automated immunosuppressant drug (ISD) assays on a single integrated chemistry system. The four ISD tests—mycophenolic acid, cyclosporine, tacrolimus and sirolimus—are the most commonly prescribed immunosuppressants used by physicians to prevent organ rejection. Now, they can be run simultaneously with routine chemistry tests on the Dimension systems, enabling more comprehensive care for transplant patients. More

Malvern, Pa., February 3, 2012 – Siemens Healthcare has been awarded the 2011 “Best in KLAS” award for laboratory information systems (LIS) by KLAS, an independent healthcare research firm. ¹ This is the fourth year in a row that NOVIUS Lab has achieved this award, which is given to a vendor or product that scores the highest in its industry segment and provides the broadest operational and clinical impact to healthcare organizations. More

Malvern, Pa., January 20, 2012 – Siemens Healthcare has joined with LMT Lammers Medical Technology GmbH to exclusively offer the nomag® IC – LMT’s MR Diagnostics Incubator System for the transport of newborns and premature babies¹ – as an add-on to Siemens’ 1.5T and 3T MR systems, including the MAGNETOM® Aera and Skyra systems. The nomag IC enables newborns and premature babies to be examined after birth with magnetic resonance imaging (MRI) via optimal, noninvasive diagnostics. The incubator facilitates safe, convenient transport from the neonatal intensive care unit (NICU) to the MRI department with an MR-conditional trolley, MR-conditional gas and power supply, and attendant conditional accessories. More

Malvern, Pa., January 11, 2012 – Siemens Healthcare has announced that Release 2.0 of the ACUSON SC2000™ volume imaging ultrasound system has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the United States. This latest version of the ACUSON SC2000 system – Siemens’ pioneering premier echocardiography system – elevates volume imaging in echocardiography to a new level, delivering significant performance and imaging enhancements to improve workflow and patient outcomes. Release 2.0 offers a host of new applications, including the quantification of the 3D proximal isovelocity surface area (PISA) to assess the severity of valvular disease and volumetric color Doppler. Other applications include a comprehensive package for automated left ventricle analysis (LVA), which enables the auto-detection and tracking of volume contours, and Siemens’ exclusive IN Focus coherent image-forming technology, which yields a high level of image uniformity and clinical detail. Release 2.0 supports volumetric intracardiac echocardiography (ICE), enabling integration of the ACUSON AcuNav™ ultrasound catheters. More

Malvern, Pa., January 9, 2012 — Siemens Healthcare and Social Media Today LLC have announced a collaborative agreement whereby Siemens will provide exclusive sponsorship of the Healthworks Collective (www.healthworkscollective.com.), which is an editorially independent, moderated community for thought leaders in international healthcare. As part of this ongoing sponsorship, Siemens experts will contribute content and resources to inform the group’s discussions on aspects of medical technology, healthcare informatics and healthcare reform. It also provides a forum for healthcare professionals to debate the latest issues and advances. More

Tarrytown, N.Y., January 6, 2012 – The Siemens Healthcare Diagnostics VERSANT® HCV RNA 1.0 Assay is now CE-marked for use on the company’s VERSANT kPCR Molecular System, giving laboratories in Europe and Australia access to a new test to aid in the management of individuals infected with hepatitis C (HCV) who are undergoing antiviral therapy. 1,2 This new, highly sensitive automated viral load assay is an important addition to the company’s portfolio of diagnostic solutions for managing patients with liver disease, which includes routine chemistry tests, hepatitis serology tests, viral load testing and ultrasound systems. More